Brand profile · Medical Device

muPharma

Melbourne, Victoria-based muPharma operates in Medical Device. It is privately held, and its site is mupharma.com. It holds one address on record, all in Australia. Headcount on record is 3. One Australian registration (ABN) is a confirmed match. It is listed alongside three similar brands, mostly in Nanotechnology Research.

Profile live Privately Held 1 entity ABN 1 office country
Registry verified · ABR

Key facts

Counted staff
3
self-reported 2–10 band
Founded
Not recorded
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity
  • MUPHARMA PTY. LTD.

    ABN84162985551

    VICHigh confidenceMatched on exact nameABR

Legal entities

muPharma: 1 registry entitymuPharma is linked to 1 registry entity: MUPHARMA PTY. LTD. (ABN 84162985551, candidate).muPharmaMUPHARMA PTY. LTD.ABN 84162985551Candidate · High confidence
Show as table · muPharma: 1 registry entity
muPharma: 1 registry entity
MUPHARMA PTY. LTD.ABN 84162985551
Confirmed matches0 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

muPharma is a business based in Victoria, Australia that has developed various novel, ultrasound based, non-invasive devices to deliver drugs and vaccines to the body that would ordinarily require injections or other highly invasive delivery means. Principal sites of application include the eye (anterior and posterior segment) and the inside of the mouth.

Ocular opportunities include:

1) Non-invasive delivery of biologics (including nucleic acid based personalised drugs and monoclonal antibody drugs) to the retina (via the uveal tract) particularly for the treatment of (dry and wet) AMD, DME and genetically inherited diseases;

2) Non-invasive delivery of Riboflavin to the cornea; and 3) Non-invasive delivery of any chemically synthesised drug to anterior / posterior segments.

Immunology opportunities include the creation of protective, long lasting mucosal immunity and systemic against diseases that enter the body via mucous membranes including COVID-19, Influenza, Norovirus, Chlamydia, HIV, Tuberculosis as well as a host of other communicable pathogens.

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary AU. Codes: AU.1 countryprimary AUAU
Show as table · Offices in 1 country
Offices in 1 country
Countries1
Primary countryAU

All codes: AU

Addresses

  • AUMelbourne, Victoria 3142Primary

Grid intelligence Members

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

3 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Names are withheld until a consented source exists.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under muPharma?

One Victoria entity on the ABR: MUPHARMA PTY. LTD. (ABN 84 162 985 551), high confidence.

How many people work at muPharma?

3 counted staff profiles at January 2026, inside the self-reported 2–10 band.

Where does muPharma have offices?

One address on record, Australia only. Primary: Melbourne, Victoria 3142.

Has muPharma raised funding?

None linked to this brand.

Which companies are listed alongside muPharma?

3 profiles list muPharma as a peer — 64th percentile in Medical Device. It lists four peers of its own. JD SANMED lists it back.

What is muPharma's website?